NCT00362297View on ClinicalTrials.gov

Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2

PHASE4CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

September 30, 2011

Conditions
Genital Herpes
Interventions
DRUG

acyclovir

800 mg orally three times daily for 7 weeks

DRUG

valacyclovir

500 mg orally once daily for 7 weeks

Trial Locations (1)

98104

University of Washington Virology Research Clinic, Seattle

All Listed Sponsors
lead

University of Washington

OTHER

NCT00362297 - Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2 | Biotech Hunter | Biotech Hunter